David Hess
EVP, Med Affairs & Dean, MCG
Professor
Academic Appointment(s)
Medical College of Georgia
Department of Neurology
Medical College of Georgia
Department of Medicine
Administration
Department of The Graduate School
Other Duties
Presidential Distinguished Chair, Neurology
Bio
David C. Hess MD, a stroke specialist, federally funded investigator, honored educator and biotech entrepreneur, is the 27th Dean of the Medical College of Georgia and Executive Vice President for Medical Affairs and Integration at Augusta University.
Dr. Hess also continues to serve as Presidential Distinguished Chair and as a Professor in the MCG Department of Neurology. He is a graduate of the Johns Hopkins University and the University of Maryland School of Medicine. He is triple board certified in Internal Medicine, Neurology, and Vascular Neurology. He completed his Neurology residency and Vascular Neurology/Stroke fellowship at MCG and AU Health System.
- DHESS@augusta.edu
- (706) 721-2231
- AA 1006
Education
-
MD, Medicine
University of Maryland - Balti, 1983
-
BA, Humanities/Humanistic Studies
Johns Hopkins University, 1979
Certifications
-
PHY
State of GA, 1986
-
ABPNVN
ABPN, 2008
-
ABPN
ABPN, 1990
-
ABIM
ABIM, 1986
Awards & Honors
-
Exemplary Teaching Award for Medical Student Education
MCG, 2025
-
Exemplary Teaching Award for Medical Student Education
MCG, 2024
-
Exemplary Teaching Award for Medical Student Education
MCG, 2023
-
Regents' Entrepreneur
University System of Georgia, 2023
-
Exemplary Teaching Award for Medical Student Education
MCG, 2022
Courses Taught Most Recent Academic Year
Teaching Interests
Dr. Hess lectures in the MCG Brain and Behavior Module focusing in the area of remote ischemic limb conditioning (RIC) as a treatment for acute ischemic stroke and vascular cognitive impairment.
Scholarship
Selected Recent Publications
- Altered endocannabinoid metabolism compromises the brain-CSF barrier and exacerbates chronic deficits after traumatic brain injury in mice., 2023
Journal Article, Academic Journal
- The time dimension to stroke: Circadian effects on stroke outcomes and mechanisms., 2023
Journal Article, Academic Journal
- Chronic remote ischaemic conditioning in patients with symptomatic intracranial atherosclerotic stenosis (the RICA trial): a multicentre, randomised, double-blind sham-controlled trial in China., 2022
Journal Article, Academic Journal
- Recycled Translation: Repurposing Drugs for Stroke., 2022
Journal Article, Academic Journal
- Neuropsychiatric sequelae of long COVID-19: Pilot results from the COVID-19 neurological and molecular prospective cohort study in Georgia, USA., 2022
Journal Article, Academic Journal
Research Interests
Dr. Hess has a major interest in the area of remote ischemic limb conditioning (RIC) as a treatment for acute ischemic stroke and vascular cognitive impairment. Dr. Hess has over 250 peer-reviewed publications and has been involved in basic, pre-clinical and clinical stroke research. He currently is the Principal Investigator on two National Institutes of Health grants.
